| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| RNA, Long Noncoding | 4 | 2018 | 408 | 1.22 | Why? |
| Dendritic Cells | 8 | 2018 | 1330 | 1.12 | Why? |
| Diabetic Nephropathies | 2 | 2018 | 315 | 1.04 | Why? |
| Fibrosis | 6 | 2018 | 800 | 0.97 | Why? |
| Cell Proliferation | 14 | 2019 | 1973 | 0.96 | Why? |
| Single-Cell Analysis | 5 | 2021 | 2450 | 0.94 | Why? |
| Cyclin-Dependent Kinase 5 | 2 | 2018 | 4 | 0.92 | Why? |
| Protein-Arginine N-Methyltransferases | 2 | 2019 | 12 | 0.92 | Why? |
| Leukemia, Erythroblastic, Acute | 2 | 2017 | 5 | 0.91 | Why? |
| Sirtuin 1 | 3 | 2018 | 100 | 0.86 | Why? |
| Scavenger Receptors, Class E | 2 | 2017 | 50 | 0.82 | Why? |
| Apoptosis | 8 | 2018 | 2335 | 0.81 | Why? |
| Hepatitis B | 3 | 2017 | 888 | 0.80 | Why? |
| MicroRNAs | 6 | 2019 | 1787 | 0.78 | Why? |
| Hepatitis B, Chronic | 4 | 2017 | 616 | 0.77 | Why? |
| Glomerular Mesangium | 1 | 2018 | 5 | 0.76 | Why? |
| Diabetes Mellitus, Experimental | 2 | 2018 | 192 | 0.76 | Why? |
| Immunoglobulin Isotypes | 1 | 2021 | 308 | 0.76 | Why? |
| Visual Cortex | 1 | 2018 | 12 | 0.74 | Why? |
| Sirtuin 2 | 1 | 2017 | 8 | 0.73 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 291 | 0.73 | Why? |
| Collateral Circulation | 1 | 2018 | 56 | 0.73 | Why? |
| Inhalant Abuse | 1 | 2017 | 6 | 0.72 | Why? |
| Visual Perception | 1 | 2018 | 49 | 0.72 | Why? |
| Imagination | 1 | 2018 | 25 | 0.72 | Why? |
| Histone Code | 1 | 2017 | 25 | 0.71 | Why? |
| Amygdala | 1 | 2017 | 42 | 0.70 | Why? |
| Metabolomics | 2 | 2021 | 921 | 0.69 | Why? |
| Sulfones | 1 | 2017 | 66 | 0.69 | Why? |
| Histones | 2 | 2017 | 371 | 0.69 | Why? |
| Nitrites | 1 | 2017 | 43 | 0.69 | Why? |
| Parity | 1 | 2018 | 122 | 0.69 | Why? |
| Enterobacter cloacae | 1 | 2017 | 58 | 0.68 | Why? |
| Paclitaxel | 4 | 2018 | 124 | 0.68 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.68 | Why? |
| Essential Hypertension | 1 | 2017 | 48 | 0.66 | Why? |
| Phimosis | 1 | 2016 | 1 | 0.65 | Why? |
| Foreskin | 1 | 2016 | 4 | 0.65 | Why? |
| Coronary Occlusion | 1 | 2018 | 138 | 0.64 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.63 | Why? |
| Glycine | 1 | 2017 | 203 | 0.62 | Why? |
| Sutures | 1 | 2016 | 57 | 0.61 | Why? |
| HIV-1 | 4 | 2018 | 3365 | 0.60 | Why? |
| Circumcision, Male | 1 | 2016 | 57 | 0.60 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.60 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.59 | Why? |
| Transforming Growth Factor beta | 2 | 2017 | 363 | 0.59 | Why? |
| Mice | 29 | 2021 | 21357 | 0.59 | Why? |
| Cholesterol, HDL | 1 | 2018 | 439 | 0.58 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.57 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.55 | Why? |
| Suture Techniques | 1 | 2016 | 138 | 0.55 | Why? |
| Choice Behavior | 1 | 2018 | 319 | 0.54 | Why? |
| Receptors, Virus | 3 | 2021 | 5659 | 0.54 | Why? |
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 896 | 0.54 | Why? |
| Cell Culture Techniques | 2 | 2019 | 704 | 0.53 | Why? |
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2013 | 19 | 0.53 | Why? |
| Thymelaeaceae | 3 | 2017 | 3 | 0.51 | Why? |
| P-Selectin | 1 | 2014 | 224 | 0.51 | Why? |
| Hand | 1 | 2017 | 449 | 0.49 | Why? |
| Animals | 54 | 2021 | 78931 | 0.48 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.47 | Why? |
| Cisplatin | 3 | 2018 | 209 | 0.47 | Why? |
| Disposable Equipment | 1 | 2016 | 332 | 0.47 | Why? |
| Signal Transduction | 10 | 2019 | 7207 | 0.45 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.45 | Why? |
| Antibodies, Monoclonal | 3 | 2021 | 8041 | 0.45 | Why? |
| Homosexuality, Male | 2 | 2018 | 1158 | 0.45 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.45 | Why? |
| Sequence Analysis, RNA | 2 | 2020 | 2290 | 0.45 | Why? |
| Antineoplastic Agents | 2 | 2017 | 3550 | 0.45 | Why? |
| Hepatitis B virus | 3 | 2017 | 882 | 0.45 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.44 | Why? |
| Pulmonary Artery | 2 | 2019 | 803 | 0.43 | Why? |
| Rats | 12 | 2019 | 2764 | 0.42 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.42 | Why? |
| Carcinoma, Hepatocellular | 2 | 2017 | 1222 | 0.42 | Why? |
| Myelodysplastic Syndromes | 3 | 2018 | 261 | 0.41 | Why? |
| Plant Proteins | 3 | 2017 | 194 | 0.41 | Why? |
| Drugs, Chinese Herbal | 2 | 2017 | 2760 | 0.41 | Why? |
| Rats, Sprague-Dawley | 9 | 2019 | 987 | 0.41 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.40 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.39 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.39 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.38 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.38 | Why? |
| Social Behavior | 1 | 2017 | 882 | 0.38 | Why? |
| Penis | 3 | 2018 | 101 | 0.37 | Why? |
| HIV Infections | 4 | 2018 | 11620 | 0.37 | Why? |
| Behavior, Animal | 3 | 2018 | 136 | 0.37 | Why? |
| Fatty Liver | 1 | 2012 | 299 | 0.37 | Why? |
| Delivery, Obstetric | 1 | 2018 | 1292 | 0.36 | Why? |
| Liver Neoplasms | 2 | 2017 | 1666 | 0.36 | Why? |
| Mice, Transgenic | 4 | 2017 | 2739 | 0.36 | Why? |
| Coated Materials, Biocompatible | 3 | 2018 | 113 | 0.36 | Why? |
| Depressive Disorder, Major | 1 | 2017 | 852 | 0.36 | Why? |
| Nucleocapsid Proteins | 2 | 2020 | 3120 | 0.36 | Why? |
| Kisspeptins | 2 | 2017 | 9 | 0.36 | Why? |
| Transcription Factors | 3 | 2018 | 784 | 0.35 | Why? |
| Lung Neoplasms | 4 | 2019 | 3228 | 0.34 | Why? |
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 1014 | 0.34 | Why? |
| Genotype | 5 | 2018 | 4697 | 0.34 | Why? |
| Immune Evasion | 1 | 2018 | 2081 | 0.33 | Why? |
| Rabies Vaccines | 2 | 2017 | 106 | 0.31 | Why? |
| Endothelial Cells | 3 | 2019 | 2048 | 0.31 | Why? |
| Polymers | 3 | 2018 | 507 | 0.31 | Why? |
| Disease Models, Animal | 13 | 2021 | 10998 | 0.30 | Why? |
| Hypoxia | 3 | 2019 | 3626 | 0.30 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 1322 | 0.29 | Why? |
| Rabies | 2 | 2017 | 113 | 0.29 | Why? |
| Mice, Inbred C57BL | 9 | 2021 | 5542 | 0.29 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.29 | Why? |
| Neuroprotective Agents | 2 | 2018 | 240 | 0.29 | Why? |
| Burns | 1 | 2011 | 466 | 0.28 | Why? |
| Blotting, Western | 5 | 2018 | 863 | 0.28 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2017 | 28 | 0.28 | Why? |
| Intraocular Pressure | 2 | 2017 | 276 | 0.28 | Why? |
| Mice, Nude | 4 | 2018 | 340 | 0.28 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.28 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.27 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.27 | Why? |
| Male | 65 | 2021 | 367725 | 0.27 | Why? |
| Humans | 101 | 2021 | 930598 | 0.27 | Why? |
| Personnel, Hospital | 1 | 2017 | 2273 | 0.26 | Why? |
| Mice, Inbred BALB C | 8 | 2021 | 5814 | 0.26 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4545 | 0.26 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.26 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.25 | Why? |
| Neurons | 3 | 2018 | 864 | 0.25 | Why? |
| Prostatectomy | 2 | 2018 | 485 | 0.25 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.25 | Why? |
| Patient Satisfaction | 1 | 2016 | 2517 | 0.24 | Why? |
| Xenograft Model Antitumor Assays | 3 | 2018 | 274 | 0.24 | Why? |
| Proteins | 3 | 2018 | 921 | 0.24 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.24 | Why? |
| Prostatic Neoplasms | 4 | 2018 | 1637 | 0.24 | Why? |
| Cell Line | 9 | 2021 | 12040 | 0.24 | Why? |
| Polymorphism, Single Nucleotide | 5 | 2017 | 3607 | 0.23 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.23 | Why? |
| Antirheumatic Agents | 1 | 2017 | 3023 | 0.23 | Why? |
| Evoked Potentials, Somatosensory | 2 | 2018 | 40 | 0.23 | Why? |
| Mice, Knockout | 5 | 2018 | 1815 | 0.22 | Why? |
| Cell Line, Tumor | 7 | 2019 | 3608 | 0.22 | Why? |
| Urinary Bladder Neoplasms | 2 | 2019 | 614 | 0.22 | Why? |
| Ubiquitin-Protein Ligases | 2 | 2016 | 249 | 0.22 | Why? |
| Poly I-C | 2 | 2018 | 176 | 0.22 | Why? |
| Acetylation | 2 | 2017 | 124 | 0.22 | Why? |
| Proto-Oncogene Proteins c-fos | 2 | 2018 | 50 | 0.21 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.21 | Why? |
| Propiolactone | 1 | 2020 | 83 | 0.21 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.21 | Why? |
| Phantoms, Imaging | 2 | 2018 | 146 | 0.21 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.21 | Why? |
| Antigens, CD34 | 2 | 2018 | 125 | 0.21 | Why? |
| Biomarkers, Tumor | 3 | 2019 | 1314 | 0.21 | Why? |
| Forkhead Transcription Factors | 2 | 2018 | 231 | 0.21 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.21 | Why? |
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2019 | 5 | 0.20 | Why? |
| Sapogenins | 1 | 2019 | 3 | 0.20 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2018 | 10649 | 0.20 | Why? |
| Oryza | 2 | 2017 | 86 | 0.20 | Why? |
| Female | 47 | 2021 | 380317 | 0.20 | Why? |
| Cells, Cultured | 5 | 2018 | 5835 | 0.20 | Why? |
| Gene Expression | 5 | 2017 | 3332 | 0.20 | Why? |
| Gene Expression Regulation, Developmental | 2 | 2017 | 159 | 0.20 | Why? |
| Stearoyl-CoA Desaturase | 1 | 2019 | 13 | 0.20 | Why? |
| CCN Intercellular Signaling Proteins | 1 | 2018 | 4 | 0.20 | Why? |
| Up-Regulation | 5 | 2019 | 2249 | 0.20 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.20 | Why? |
| Case-Control Studies | 6 | 2020 | 17671 | 0.20 | Why? |
| Polysaccharides | 2 | 2017 | 854 | 0.20 | Why? |
| Myasthenia Gravis, Autoimmune, Experimental | 1 | 2018 | 1 | 0.20 | Why? |
| Hep G2 Cells | 2 | 2017 | 391 | 0.20 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 43 | 0.19 | Why? |
| Sexual Abstinence | 1 | 2018 | 5 | 0.19 | Why? |
| Premature Ejaculation | 1 | 2018 | 3 | 0.19 | Why? |
| Panax | 1 | 2019 | 39 | 0.19 | Why? |
| Semaphorin-3A | 1 | 2018 | 7 | 0.19 | Why? |
| Tumor Hypoxia | 1 | 2018 | 9 | 0.19 | Why? |
| Foreign-Body Reaction | 1 | 2018 | 8 | 0.19 | Why? |
| Human Immunodeficiency Virus Proteins | 1 | 2018 | 20 | 0.19 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.19 | Why? |
| Estrogen Receptor beta | 1 | 2018 | 14 | 0.19 | Why? |
| Adult | 35 | 2021 | 244371 | 0.19 | Why? |
| Rheum | 1 | 2018 | 12 | 0.19 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.19 | Why? |
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2018 | 1 | 0.19 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.19 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.19 | Why? |
| Cardiac Catheters | 1 | 2018 | 44 | 0.19 | Why? |
| Epiregulin | 1 | 2017 | 1 | 0.19 | Why? |
| Bone Regeneration | 1 | 2018 | 35 | 0.18 | Why? |
| Plant Weeds | 1 | 2017 | 3 | 0.18 | Why? |
| Azides | 1 | 2018 | 19 | 0.18 | Why? |
| Neoplasms, Experimental | 1 | 2018 | 67 | 0.18 | Why? |
| Megakaryocytes | 1 | 2021 | 274 | 0.18 | Why? |
| Transcription Elongation, Genetic | 1 | 2017 | 2 | 0.18 | Why? |
| Piperidones | 1 | 2017 | 4 | 0.18 | Why? |
| N-Myc Proto-Oncogene Protein | 1 | 2017 | 6 | 0.18 | Why? |
| Elastic Tissue | 1 | 2017 | 14 | 0.18 | Why? |
| Phenethylamines | 1 | 2017 | 8 | 0.18 | Why? |
| Epirubicin | 1 | 2017 | 21 | 0.18 | Why? |
| Gels | 1 | 2018 | 111 | 0.18 | Why? |
| Cation Transport Proteins | 1 | 2018 | 53 | 0.18 | Why? |
| Acrylamides | 1 | 2018 | 40 | 0.18 | Why? |
| rho GTP-Binding Proteins | 1 | 2017 | 18 | 0.18 | Why? |
| Phosphoproteins | 2 | 2020 | 4346 | 0.18 | Why? |
| Tephritidae | 1 | 2017 | 1 | 0.18 | Why? |
| Impotence, Vasculogenic | 1 | 2017 | 3 | 0.18 | Why? |
| Mammary Neoplasms, Experimental | 1 | 2017 | 21 | 0.18 | Why? |
| HIV Long Terminal Repeat | 1 | 2017 | 16 | 0.18 | Why? |
| Flowers | 1 | 2017 | 31 | 0.18 | Why? |
| Interferon-gamma | 4 | 2017 | 2711 | 0.18 | Why? |
| CD40 Antigens | 1 | 2018 | 118 | 0.18 | Why? |
| Morphogenesis | 1 | 2017 | 43 | 0.18 | Why? |
| K562 Cells | 1 | 2017 | 91 | 0.18 | Why? |
| Organoplatinum Compounds | 1 | 2017 | 76 | 0.18 | Why? |
| Antibiotics, Antineoplastic | 1 | 2018 | 128 | 0.18 | Why? |
| Serine | 1 | 2017 | 90 | 0.18 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 59 | 0.18 | Why? |
| Bacillus cereus | 1 | 2017 | 13 | 0.18 | Why? |
| Receptors, Neurotransmitter | 1 | 2017 | 10 | 0.18 | Why? |
| Pelvis | 1 | 2018 | 125 | 0.18 | Why? |
| China | 15 | 2021 | 50654 | 0.18 | Why? |
| Transplantation Tolerance | 1 | 2017 | 13 | 0.18 | Why? |
| HEK293 Cells | 6 | 2021 | 8394 | 0.18 | Why? |
| Osteoclasts | 1 | 2018 | 67 | 0.18 | Why? |
| Plant Extracts | 3 | 2018 | 1514 | 0.18 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 67 | 0.18 | Why? |
| Astragalus Plant | 1 | 2017 | 16 | 0.18 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2018 | 93 | 0.18 | Why? |
| Benzylidene Compounds | 1 | 2017 | 26 | 0.18 | Why? |
| Emperipolesis | 1 | 2017 | 5 | 0.18 | Why? |
| Osteosarcoma | 1 | 2018 | 83 | 0.18 | Why? |
| Mesangial Cells | 1 | 2017 | 5 | 0.18 | Why? |
| CA1 Region, Hippocampal | 1 | 2017 | 12 | 0.18 | Why? |
| Bone Resorption | 1 | 2018 | 61 | 0.17 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 40 | 0.17 | Why? |
| Arginine Vasopressin | 1 | 2017 | 14 | 0.17 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2017 | 138 | 0.17 | Why? |
| Mosaicism | 1 | 2017 | 44 | 0.17 | Why? |
| Electroacupuncture | 1 | 2017 | 12 | 0.17 | Why? |
| Proto-Oncogene Proteins c-jun | 1 | 2017 | 21 | 0.17 | Why? |
| Preimplantation Diagnosis | 1 | 2017 | 16 | 0.17 | Why? |
| Heat-Shock Response | 1 | 2017 | 47 | 0.17 | Why? |
| Insect Proteins | 1 | 2017 | 39 | 0.17 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.17 | Why? |
| Lymphatic Metastasis | 2 | 2017 | 537 | 0.17 | Why? |
| Perforator Flap | 1 | 2016 | 15 | 0.17 | Why? |
| Prostheses and Implants | 1 | 2018 | 116 | 0.17 | Why? |
| Indocyanine Green | 1 | 2017 | 66 | 0.17 | Why? |
| Hepatic Stellate Cells | 1 | 2017 | 35 | 0.17 | Why? |
| Femur | 1 | 2018 | 100 | 0.17 | Why? |
| Penile Induration | 1 | 2017 | 53 | 0.17 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 96 | 0.17 | Why? |
| Thiophenes | 1 | 2018 | 78 | 0.17 | Why? |
| Lysophospholipids | 1 | 2018 | 74 | 0.17 | Why? |
| Epilepsies, Myoclonic | 1 | 2017 | 30 | 0.17 | Why? |
| Vinblastine | 1 | 2017 | 48 | 0.17 | Why? |
| Iodine Radioisotopes | 1 | 2018 | 124 | 0.17 | Why? |
| Groin | 1 | 2016 | 22 | 0.17 | Why? |
| Retroperitoneal Neoplasms | 1 | 2017 | 17 | 0.17 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 159 | 0.17 | Why? |
| Certolizumab Pegol | 1 | 2017 | 36 | 0.17 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.17 | Why? |
| Active Transport, Cell Nucleus | 1 | 2017 | 203 | 0.17 | Why? |
| Hypertrophy, Right Ventricular | 1 | 2017 | 33 | 0.17 | Why? |
| Dopaminergic Neurons | 1 | 2017 | 59 | 0.17 | Why? |
| Sesquiterpenes | 1 | 2017 | 77 | 0.17 | Why? |
| alpha-Synuclein | 1 | 2017 | 71 | 0.17 | Why? |
| Seeds | 1 | 2017 | 114 | 0.17 | Why? |
| Histamine H2 Antagonists | 1 | 2018 | 111 | 0.17 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.17 | Why? |
| Rest | 1 | 2018 | 188 | 0.17 | Why? |
| Optic Disk | 1 | 2017 | 66 | 0.17 | Why? |
| Middle Aged | 35 | 2021 | 270681 | 0.17 | Why? |
| Drug Synergism | 2 | 2018 | 833 | 0.16 | Why? |
| Infant Formula | 1 | 2017 | 64 | 0.16 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2017 | 113 | 0.16 | Why? |
| Enterotoxins | 1 | 2017 | 115 | 0.16 | Why? |
| Coronary Restenosis | 1 | 2018 | 153 | 0.16 | Why? |
| Glaucoma, Open-Angle | 1 | 2017 | 55 | 0.16 | Why? |
| Fluorouracil | 1 | 2017 | 169 | 0.16 | Why? |
| Glycosides | 1 | 2017 | 94 | 0.16 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.16 | Why? |
| Spinal Fractures | 1 | 2018 | 124 | 0.16 | Why? |
| Hematopoiesis | 1 | 2017 | 168 | 0.16 | Why? |
| Neural Pathways | 1 | 2018 | 155 | 0.16 | Why? |
| Hepatitis B Antibodies | 1 | 2017 | 142 | 0.16 | Why? |
| Algorithms | 4 | 2018 | 7346 | 0.16 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2017 | 64 | 0.16 | Why? |
| Carcinogenesis | 1 | 2019 | 236 | 0.16 | Why? |
| ErbB Receptors | 1 | 2019 | 320 | 0.16 | Why? |
| Coloring Agents | 1 | 2017 | 116 | 0.16 | Why? |
| Ubiquitins | 1 | 2018 | 202 | 0.16 | Why? |
| Radionuclide Imaging | 1 | 2018 | 184 | 0.16 | Why? |
| Cell Hypoxia | 1 | 2017 | 141 | 0.16 | Why? |
| Cyclooxygenase 2 | 1 | 2017 | 129 | 0.16 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 54 | 0.16 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2018 | 249 | 0.16 | Why? |
| Skin Transplantation | 1 | 2016 | 50 | 0.16 | Why? |
| Food Microbiology | 1 | 2017 | 114 | 0.16 | Why? |
| Brain Mapping | 1 | 2018 | 228 | 0.16 | Why? |
| Foodborne Diseases | 1 | 2017 | 89 | 0.16 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2019 | 242 | 0.16 | Why? |
| Methylation | 1 | 2017 | 332 | 0.16 | Why? |
| Tissue Scaffolds | 1 | 2018 | 174 | 0.16 | Why? |
| Ovary | 1 | 2017 | 133 | 0.16 | Why? |
| Diabetic Cardiomyopathies | 1 | 2017 | 79 | 0.16 | Why? |
| Doxorubicin | 1 | 2018 | 313 | 0.16 | Why? |
| Neuropeptides | 1 | 2017 | 91 | 0.16 | Why? |
| Proto-Oncogene Proteins | 1 | 2018 | 340 | 0.16 | Why? |
| Estradiol | 1 | 2018 | 250 | 0.16 | Why? |
| Deoxycytidine | 1 | 2017 | 116 | 0.16 | Why? |
| Reperfusion Injury | 1 | 2018 | 178 | 0.16 | Why? |
| Lysine | 1 | 2016 | 153 | 0.16 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 152 | 0.15 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.15 | Why? |
| Visual Fields | 1 | 2017 | 123 | 0.15 | Why? |
| Food Contamination | 1 | 2017 | 142 | 0.15 | Why? |
| Pharmacogenetics | 1 | 2017 | 222 | 0.15 | Why? |
| Proteomics | 2 | 2017 | 2481 | 0.15 | Why? |
| Osteoporotic Fractures | 1 | 2018 | 175 | 0.15 | Why? |
| Chlorhexidine | 1 | 2017 | 176 | 0.15 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.15 | Why? |
| Etanercept | 1 | 2017 | 162 | 0.15 | Why? |
| Basigin | 2 | 2017 | 276 | 0.15 | Why? |
| Lymph Node Excision | 1 | 2018 | 362 | 0.15 | Why? |
| Toll-Like Receptor 3 | 1 | 2018 | 391 | 0.15 | Why? |
| Aspergillus fumigatus | 1 | 2018 | 239 | 0.15 | Why? |
| Minimally Invasive Surgical Procedures | 2 | 2018 | 663 | 0.15 | Why? |
| Cell Death | 1 | 2018 | 536 | 0.15 | Why? |
| Surgical Flaps | 1 | 2017 | 188 | 0.15 | Why? |
| Down-Regulation | 3 | 2018 | 1416 | 0.15 | Why? |
| Lipids | 3 | 2019 | 1079 | 0.15 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2017 | 187 | 0.15 | Why? |
| Endometrial Neoplasms | 1 | 2017 | 120 | 0.15 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.15 | Why? |
| Organ Specificity | 1 | 2020 | 1070 | 0.15 | Why? |
| Hepatitis B Surface Antigens | 1 | 2017 | 305 | 0.15 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.15 | Why? |
| Chemoradiotherapy | 1 | 2018 | 362 | 0.15 | Why? |
| Cardiotoxicity | 1 | 2018 | 365 | 0.15 | Why? |
| Iron Overload | 1 | 2017 | 113 | 0.15 | Why? |
| Nucleic Acids | 1 | 2020 | 435 | 0.15 | Why? |
| Tissue and Organ Harvesting | 1 | 2016 | 146 | 0.15 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.15 | Why? |
| Peripheral Nervous System Diseases | 1 | 2017 | 193 | 0.15 | Why? |
| Demyelinating Diseases | 1 | 2017 | 224 | 0.15 | Why? |
| Hepatitis B Vaccines | 1 | 2017 | 245 | 0.15 | Why? |
| Amyloid beta-Peptides | 1 | 2017 | 185 | 0.15 | Why? |
| Cell Survival | 2 | 2018 | 1581 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2019 | 447 | 0.14 | Why? |
| Quality Improvement | 2 | 2018 | 2435 | 0.14 | Why? |
| Pulmonary Embolism | 1 | 2014 | 4775 | 0.14 | Why? |
| Monocytes | 3 | 2021 | 2978 | 0.14 | Why? |
| T-Lymphocytes, Regulatory | 2 | 2018 | 698 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Carcinoma, Transitional Cell | 1 | 2017 | 198 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2018 | 418 | 0.14 | Why? |
| Transplantation Conditioning | 1 | 2017 | 323 | 0.14 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2018 | 365 | 0.14 | Why? |
| Copper | 1 | 2018 | 288 | 0.14 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.14 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.14 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.14 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.14 | Why? |
| Thalassemia | 1 | 2017 | 144 | 0.14 | Why? |
| Retinal Vessels | 1 | 2017 | 255 | 0.14 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.14 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.14 | Why? |
| Sepsis | 1 | 2011 | 3517 | 0.14 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.14 | Why? |
| Models, Theoretical | 1 | 2013 | 6659 | 0.14 | Why? |
| Fetus | 1 | 2018 | 484 | 0.13 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.13 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.13 | Why? |
| Operative Time | 1 | 2016 | 450 | 0.13 | Why? |
| Bone Marrow Transplantation | 1 | 2017 | 343 | 0.13 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.13 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.13 | Why? |
| Pyrrolidines | 1 | 2018 | 558 | 0.13 | Why? |
| Nephrectomy | 1 | 2017 | 406 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| AIDS Vaccines | 1 | 2018 | 452 | 0.13 | Why? |
| Adrenergic beta-Antagonists | 1 | 2017 | 465 | 0.13 | Why? |
| Protein Precursors | 1 | 2017 | 425 | 0.13 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.13 | Why? |
| Orphan Nuclear Receptors | 1 | 2012 | 6 | 0.13 | Why? |
| Hydrocarbons, Fluorinated | 1 | 2012 | 6 | 0.13 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.13 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.13 | Why? |
| Electrophysiology | 1 | 2013 | 64 | 0.13 | Why? |
| Young Adult | 15 | 2021 | 93724 | 0.13 | Why? |
| Macaca fascicularis | 1 | 2017 | 1009 | 0.12 | Why? |
| Adalimumab | 1 | 2017 | 389 | 0.12 | Why? |
| Infertility, Male | 1 | 2018 | 322 | 0.12 | Why? |
| Myeloid Cells | 2 | 2017 | 808 | 0.12 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2005 | 12361 | 0.12 | Why? |
| Papillomaviridae | 1 | 2017 | 404 | 0.12 | Why? |
| Liver | 2 | 2017 | 4007 | 0.12 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.12 | Why? |
| Immunization Schedule | 2 | 2017 | 1305 | 0.12 | Why? |
| Cardiomegaly | 1 | 2013 | 96 | 0.12 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.12 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.12 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.12 | Why? |
| Perioperative Period | 3 | 2018 | 276 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.12 | Why? |
| Drug-Eluting Stents | 1 | 2018 | 562 | 0.12 | Why? |
| Post-Exposure Prophylaxis | 1 | 2017 | 472 | 0.12 | Why? |
| Peptide Hydrolases | 1 | 2020 | 1269 | 0.12 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.12 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| Pancreatic Neoplasms | 1 | 2019 | 609 | 0.11 | Why? |
| Testis | 1 | 2017 | 566 | 0.11 | Why? |
| Wound Healing | 1 | 2016 | 424 | 0.11 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.11 | Why? |
| Statistics as Topic | 1 | 2014 | 370 | 0.11 | Why? |
| Escherichia coli | 2 | 2016 | 1547 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Virus Replication | 1 | 2012 | 14331 | 0.11 | Why? |
| Drug Delivery Systems | 1 | 2021 | 1365 | 0.11 | Why? |
| Transcriptome | 2 | 2021 | 3466 | 0.11 | Why? |
| Neurodegenerative Diseases | 1 | 2017 | 469 | 0.11 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Neoplasm Metastasis | 3 | 2019 | 682 | 0.11 | Why? |
| Graft Survival | 1 | 2014 | 587 | 0.11 | Why? |
| Myocytes, Cardiac | 2 | 2018 | 804 | 0.11 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.11 | Why? |
| Software | 2 | 2020 | 2501 | 0.11 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.11 | Why? |
| Vitiligo | 1 | 2011 | 76 | 0.11 | Why? |
| Zinc | 1 | 2018 | 817 | 0.11 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.10 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.10 | Why? |
| Genetic Loci | 1 | 2012 | 439 | 0.10 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2020 | 5837 | 0.10 | Why? |
| Disinfectants | 1 | 2020 | 1077 | 0.10 | Why? |
| Killer Cells, Natural | 2 | 2017 | 2093 | 0.10 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.10 | Why? |
| Cardiomyopathy, Dilated | 1 | 2013 | 251 | 0.10 | Why? |
| Aged | 21 | 2021 | 215776 | 0.10 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2017 | 1261 | 0.10 | Why? |
| Aorta, Thoracic | 1 | 2012 | 271 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Spleen | 1 | 2014 | 877 | 0.10 | Why? |
| Hypertension, Pulmonary | 1 | 2019 | 970 | 0.10 | Why? |
| Plasmids | 3 | 2018 | 840 | 0.10 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.10 | Why? |
| Ventricular Remodeling | 1 | 2013 | 349 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Cysteine Endopeptidases | 1 | 2018 | 1557 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2019 | 1585 | 0.09 | Why? |
| Flow Cytometry | 4 | 2018 | 2393 | 0.09 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.09 | Why? |
| Terminology as Topic | 1 | 2014 | 546 | 0.09 | Why? |
| Rats, Inbred Lew | 2 | 2018 | 45 | 0.09 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.09 | Why? |
| Equipment Design | 2 | 2018 | 3095 | 0.09 | Why? |
| Hepatitis B Core Antigens | 1 | 2008 | 76 | 0.09 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2017 | 2483 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.09 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.09 | Why? |
| Adrenal Cortex Hormones | 1 | 2005 | 6537 | 0.09 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.09 | Why? |
| Base Sequence | 4 | 2016 | 3581 | 0.09 | Why? |
| Plaque, Atherosclerotic | 1 | 2012 | 423 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2017 | 1709 | 0.09 | Why? |
| Reconstructive Surgical Procedures | 1 | 2017 | 860 | 0.09 | Why? |
| Genome-Wide Association Study | 2 | 2012 | 1648 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2018 | 2262 | 0.08 | Why? |
| Oligodeoxyribonucleotides | 3 | 2017 | 206 | 0.08 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.08 | Why? |
| Pregnancy | 3 | 2018 | 23879 | 0.08 | Why? |
| Interferon-alpha | 3 | 2017 | 1442 | 0.08 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.08 | Why? |
| Enzyme Inhibitors | 1 | 2017 | 1881 | 0.08 | Why? |
| Betaine | 1 | 2006 | 16 | 0.08 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.08 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.08 | Why? |
| Enzyme Activation | 2 | 2018 | 425 | 0.08 | Why? |
| Bayes Theorem | 2 | 2017 | 3237 | 0.08 | Why? |
| Sensitivity and Specificity | 4 | 2020 | 22971 | 0.08 | Why? |
| B-Lymphocytes | 2 | 2020 | 4418 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.08 | Why? |
| Kidney Diseases | 1 | 2017 | 1434 | 0.08 | Why? |
| Technology, Pharmaceutical | 2 | 2017 | 82 | 0.08 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Treatment Outcome | 6 | 2018 | 51732 | 0.08 | Why? |
| Genetic Predisposition to Disease | 4 | 2018 | 4027 | 0.08 | Why? |
| Phosphatidylinositol 3-Kinases | 2 | 2018 | 347 | 0.08 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.08 | Why? |
| Diagnostic Imaging | 1 | 2014 | 1044 | 0.07 | Why? |
| HeLa Cells | 2 | 2021 | 1303 | 0.07 | Why? |
| HLA Antigens | 1 | 2011 | 830 | 0.07 | Why? |
| Carboxypeptidases | 1 | 2005 | 148 | 0.07 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.07 | Why? |
| Parkinson Disease | 1 | 2018 | 1414 | 0.07 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.07 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| MAP Kinase Signaling System | 2 | 2018 | 360 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.07 | Why? |
| Logistic Models | 3 | 2017 | 9089 | 0.07 | Why? |
| Medicine, Chinese Traditional | 1 | 2017 | 2255 | 0.07 | Why? |
| Random Allocation | 2 | 2017 | 773 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| DNA Mutational Analysis | 2 | 2017 | 581 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.07 | Why? |
| Atherosclerosis | 1 | 2012 | 768 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.07 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.07 | Why? |
| Heart Transplantation | 1 | 2014 | 1293 | 0.06 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.06 | Why? |
| Sulfonamides | 1 | 2012 | 1294 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 907 | 0.06 | Why? |
| Transfection | 2 | 2018 | 864 | 0.06 | Why? |
| Child | 7 | 2021 | 70012 | 0.06 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.06 | Why? |
| Cloning, Molecular | 2 | 2017 | 1036 | 0.06 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Infant | 3 | 2021 | 30274 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Radiopharmaceuticals | 2 | 2018 | 763 | 0.06 | Why? |
| Models, Molecular | 3 | 2021 | 7616 | 0.06 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2018 | 3892 | 0.06 | Why? |
| Tandem Mass Spectrometry | 2 | 2018 | 1031 | 0.06 | Why? |
| Liver Diseases | 1 | 2017 | 2698 | 0.06 | Why? |
| Morbidity | 2 | 2018 | 1426 | 0.06 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.06 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| Viral Structural Proteins | 1 | 2005 | 491 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| SARS Virus | 4 | 2005 | 13021 | 0.05 | Why? |
| Electron Microscope Tomography | 1 | 2020 | 167 | 0.05 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 2 | 2021 | 3776 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Cell Respiration | 1 | 2019 | 26 | 0.05 | Why? |
| Protein Conformation | 2 | 2021 | 4386 | 0.05 | Why? |
| Clone Cells | 1 | 2020 | 312 | 0.05 | Why? |
| Blood Cell Count | 1 | 2005 | 1101 | 0.05 | Why? |
| Misonidazole | 1 | 2018 | 1 | 0.05 | Why? |
| Antigens, CD | 1 | 2005 | 984 | 0.05 | Why? |
| Crystallization | 1 | 2020 | 331 | 0.05 | Why? |
| Lung | 3 | 2020 | 31049 | 0.05 | Why? |
| Ejaculation | 1 | 2018 | 8 | 0.05 | Why? |
| Inactivation, Metabolic | 1 | 2018 | 16 | 0.05 | Why? |
| Injections, Intraventricular | 1 | 2018 | 11 | 0.05 | Why? |
| Metallothionein | 1 | 2018 | 20 | 0.05 | Why? |
| Somatomedins | 1 | 2018 | 7 | 0.05 | Why? |
| PC12 Cells | 1 | 2018 | 33 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Glucosamine | 1 | 2018 | 8 | 0.05 | Why? |
| Horseradish Peroxidase | 1 | 2018 | 14 | 0.05 | Why? |
| Phosphines | 1 | 2018 | 6 | 0.05 | Why? |
| Vascular Remodeling | 1 | 2019 | 99 | 0.05 | Why? |
| Electrophysiological Phenomena | 1 | 2018 | 59 | 0.05 | Why? |
| Helix-Loop-Helix Motifs | 1 | 2017 | 1 | 0.05 | Why? |
| Vero Cells | 3 | 2021 | 14117 | 0.05 | Why? |
| Acylation | 1 | 2018 | 32 | 0.05 | Why? |
| Benz(a)Anthracenes | 1 | 2017 | 1 | 0.05 | Why? |
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2017 | 2 | 0.05 | Why? |
| Electric Stimulation | 1 | 2018 | 84 | 0.05 | Why? |
| Epigenetic Repression | 1 | 2017 | 5 | 0.05 | Why? |
| Isotope Labeling | 1 | 2018 | 39 | 0.05 | Why? |
| Electroretinography | 1 | 2017 | 26 | 0.05 | Why? |
| Euphorbia | 1 | 2018 | 14 | 0.05 | Why? |
| Aurora Kinases | 1 | 2017 | 4 | 0.05 | Why? |
| NFATC Transcription Factors | 1 | 2018 | 22 | 0.05 | Why? |
| Mammary Glands, Animal | 1 | 2017 | 9 | 0.05 | Why? |
| raf Kinases | 1 | 2017 | 7 | 0.05 | Why? |
| Micelles | 1 | 2018 | 96 | 0.05 | Why? |
| RNA, Messenger | 3 | 2017 | 5131 | 0.05 | Why? |
| Azepines | 1 | 2017 | 17 | 0.05 | Why? |
| Ovariectomy | 1 | 2018 | 53 | 0.05 | Why? |
| Heart | 2 | 2018 | 1791 | 0.05 | Why? |
| Chromosome Aberrations | 1 | 2018 | 54 | 0.05 | Why? |
| RANK Ligand | 1 | 2018 | 47 | 0.05 | Why? |
| Polymethyl Methacrylate | 1 | 2018 | 51 | 0.05 | Why? |
| Sciatic Nerve | 1 | 2017 | 26 | 0.04 | Why? |
| Oxylipins | 1 | 2017 | 29 | 0.04 | Why? |
| Heterografts | 1 | 2018 | 203 | 0.04 | Why? |
| Alkyl and Aryl Transferases | 1 | 2017 | 22 | 0.04 | Why? |
| rhoA GTP-Binding Protein | 1 | 2017 | 24 | 0.04 | Why? |
| Patient Readmission | 2 | 2017 | 1543 | 0.04 | Why? |
| Time Factors | 4 | 2018 | 31397 | 0.04 | Why? |
| Radiography, Abdominal | 1 | 2018 | 88 | 0.04 | Why? |
| Ribavirin | 1 | 2005 | 1182 | 0.04 | Why? |
| Glycolysis | 1 | 2019 | 208 | 0.04 | Why? |
| Risk Factors | 5 | 2018 | 71621 | 0.04 | Why? |
| Flour | 1 | 2017 | 17 | 0.04 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 92 | 0.04 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.04 | Why? |
| Oogenesis | 1 | 2017 | 13 | 0.04 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Sexual Behavior | 2 | 2018 | 1322 | 0.04 | Why? |
| Membrane Glycoproteins | 2 | 2004 | 2273 | 0.04 | Why? |
| MEDLINE | 1 | 2018 | 76 | 0.04 | Why? |
| Interferons | 2 | 2021 | 2885 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Histocytochemistry | 1 | 2017 | 88 | 0.04 | Why? |
| Blood Transfusion | 2 | 2017 | 1399 | 0.04 | Why? |
| Transcription Factor RelA | 1 | 2018 | 122 | 0.04 | Why? |
| Asymptomatic Infections | 1 | 2017 | 7218 | 0.04 | Why? |
| Plants, Genetically Modified | 1 | 2017 | 84 | 0.04 | Why? |
| Inheritance Patterns | 1 | 2017 | 20 | 0.04 | Why? |
| Penile Erection | 1 | 2017 | 58 | 0.04 | Why? |
| Cytochromes c | 1 | 2017 | 44 | 0.04 | Why? |
| Actins | 1 | 2017 | 108 | 0.04 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.04 | Why? |
| T-Lymphocyte Subsets | 1 | 2005 | 1387 | 0.04 | Why? |
| Gene Expression Regulation, Plant | 1 | 2017 | 110 | 0.04 | Why? |
| Visual Field Tests | 1 | 2017 | 77 | 0.04 | Why? |
| Cell Adhesion | 1 | 2018 | 230 | 0.04 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.04 | Why? |
| Arabidopsis | 1 | 2017 | 88 | 0.04 | Why? |
| Psoriasis | 1 | 2011 | 1739 | 0.04 | Why? |
| Wnt Signaling Pathway | 1 | 2017 | 87 | 0.04 | Why? |
| Blood Urea Nitrogen | 1 | 2018 | 206 | 0.04 | Why? |
| Discriminant Analysis | 1 | 2017 | 170 | 0.04 | Why? |
| Prognosis | 5 | 2018 | 32490 | 0.04 | Why? |
| tau Proteins | 1 | 2018 | 162 | 0.04 | Why? |
| Sympathetic Nervous System | 1 | 2018 | 111 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2017 | 177 | 0.04 | Why? |
| Dementia, Vascular | 1 | 2017 | 33 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Caspases | 1 | 2017 | 156 | 0.04 | Why? |
| Signal-To-Noise Ratio | 1 | 2018 | 217 | 0.04 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
| Tamoxifen | 1 | 2017 | 83 | 0.04 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Acupuncture Points | 1 | 2017 | 114 | 0.04 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.04 | Why? |
| Protein Structure, Secondary | 1 | 2021 | 1077 | 0.04 | Why? |
| Least-Squares Analysis | 1 | 2017 | 254 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.04 | Why? |
| RNA-Directed DNA Polymerase | 1 | 2017 | 170 | 0.04 | Why? |
| Cytological Techniques | 1 | 2017 | 79 | 0.04 | Why? |
| Blastocyst | 1 | 2017 | 65 | 0.04 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2016 | 107 | 0.04 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.04 | Why? |
| Biphenyl Compounds | 1 | 2018 | 249 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.04 | Why? |
| Protein Structure, Tertiary | 1 | 2021 | 1565 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Condoms | 1 | 2018 | 235 | 0.04 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Injections | 1 | 2017 | 237 | 0.04 | Why? |
| Veins | 1 | 2017 | 168 | 0.04 | Why? |
| Slit Lamp Microscopy | 1 | 2017 | 164 | 0.04 | Why? |
| Animals, Newborn | 1 | 2017 | 350 | 0.04 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2020 | 13720 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2017 | 273 | 0.04 | Why? |
| Acetates | 1 | 2017 | 123 | 0.04 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.04 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 238 | 0.04 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.04 | Why? |
| Memory | 1 | 2017 | 137 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2019 | 4020 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Oxidative Stress | 2 | 2017 | 2050 | 0.04 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2018 | 203 | 0.04 | Why? |
| Motor Activity | 1 | 2017 | 217 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.04 | Why? |
| Spine | 1 | 2018 | 292 | 0.04 | Why? |
| Perfusion Imaging | 1 | 2017 | 199 | 0.04 | Why? |
| Endothelium | 1 | 2019 | 460 | 0.04 | Why? |
| Cell Cycle Proteins | 1 | 2017 | 297 | 0.04 | Why? |
| Epithelium | 1 | 2017 | 330 | 0.04 | Why? |
| Intraoperative Complications | 1 | 2017 | 221 | 0.04 | Why? |
| Prostate | 1 | 2017 | 283 | 0.04 | Why? |
| Protein Transport | 1 | 2016 | 487 | 0.04 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3633 | 0.04 | Why? |
| Genetic Variation | 2 | 2012 | 3919 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.04 | Why? |
| Biological Assay | 1 | 2018 | 367 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.04 | Why? |
| Viral Envelope Proteins | 2 | 2004 | 3539 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2017 | 830 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.03 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
| Rabbits | 1 | 2018 | 1171 | 0.03 | Why? |
| Disease Progression | 3 | 2018 | 13580 | 0.03 | Why? |
| Cellular Senescence | 1 | 2017 | 326 | 0.03 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.03 | Why? |
| Injections, Intramuscular | 1 | 2017 | 800 | 0.03 | Why? |
| Fluorescein Angiography | 1 | 2017 | 426 | 0.03 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.03 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.03 | Why? |
| Isoproterenol | 1 | 2013 | 31 | 0.03 | Why? |
| Calcineurin | 1 | 2013 | 38 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.03 | Why? |
| Technology | 1 | 2020 | 812 | 0.03 | Why? |
| Leukocyte Count | 1 | 2004 | 3178 | 0.03 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.03 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.03 | Why? |
| Fertilization in Vitro | 1 | 2017 | 330 | 0.03 | Why? |
| Glycosylation | 1 | 2018 | 1255 | 0.03 | Why? |
| Histone Deacetylases | 1 | 2013 | 37 | 0.03 | Why? |
| Liver X Receptors | 1 | 2012 | 13 | 0.03 | Why? |
| Oncogene Protein v-akt | 1 | 2012 | 10 | 0.03 | Why? |
| Amino Acid Sequence | 2 | 2017 | 6049 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 11367 | 0.03 | Why? |
| ATP Binding Cassette Transporter 1 | 1 | 2012 | 17 | 0.03 | Why? |
| Polyethylene Glycols | 1 | 2018 | 574 | 0.03 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.03 | Why? |
| Benchmarking | 1 | 2017 | 627 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2020 | 1562 | 0.03 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2019 | 711 | 0.03 | Why? |
| Chromosomes, Human, Pair 6 | 1 | 2011 | 14 | 0.03 | Why? |
| ATP-Binding Cassette Transporters | 1 | 2012 | 48 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2012 | 87 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Sequence Deletion | 1 | 2016 | 674 | 0.03 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| HLA-DQ Antigens | 1 | 2011 | 48 | 0.03 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.03 | Why? |
| Stem Cells | 1 | 2017 | 595 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.03 | Why? |
| Chromosome Mapping | 1 | 2012 | 178 | 0.03 | Why? |
| Subarachnoid Hemorrhage | 1 | 2018 | 611 | 0.03 | Why? |
| Genes, Reporter | 1 | 2013 | 472 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Apolipoproteins E | 1 | 2012 | 170 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Vasoconstriction | 1 | 2012 | 153 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| Lipoproteins | 1 | 2012 | 240 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2016 | 919 | 0.03 | Why? |
| Calibration | 1 | 2012 | 307 | 0.03 | Why? |
| HLA-B Antigens | 1 | 2011 | 166 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Allografts | 1 | 2014 | 761 | 0.03 | Why? |
| HLA-C Antigens | 1 | 2011 | 195 | 0.03 | Why? |
| Datasets as Topic | 1 | 2017 | 1404 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.03 | Why? |
| Vasodilation | 1 | 2012 | 258 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2016 | 2219 | 0.03 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.03 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.02 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.02 | Why? |
| Models, Genetic | 1 | 2012 | 434 | 0.02 | Why? |
| Antibodies | 1 | 2016 | 846 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Genetic Vectors | 1 | 2016 | 1600 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Learning | 1 | 2017 | 1181 | 0.02 | Why? |
| Cell Transformation, Neoplastic | 1 | 2009 | 191 | 0.02 | Why? |
| 3' Untranslated Regions | 1 | 2009 | 318 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.02 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2013 | 3198 | 0.02 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.02 | Why? |
| Conserved Sequence | 1 | 2009 | 751 | 0.02 | Why? |
| Propylene Glycols | 1 | 2006 | 5 | 0.02 | Why? |
| Polymethacrylic Acids | 1 | 2006 | 10 | 0.02 | Why? |
| Serum Albumin, Bovine | 1 | 2006 | 40 | 0.02 | Why? |
| Toll-Like Receptor 9 | 1 | 2006 | 72 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2016 | 2153 | 0.02 | Why? |
| Muramidase | 1 | 2006 | 24 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Antimalarials | 1 | 2018 | 2505 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2016 | 3786 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Adsorption | 1 | 2006 | 261 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2018 | 3614 | 0.02 | Why? |
| Phylogeny | 2 | 2017 | 13341 | 0.02 | Why? |
| Cyclophilin A | 1 | 2005 | 90 | 0.02 | Why? |
| Area Under Curve | 1 | 2012 | 2564 | 0.02 | Why? |
| Regression Analysis | 1 | 2011 | 2484 | 0.02 | Why? |
| Surface Plasmon Resonance | 1 | 2006 | 440 | 0.02 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Substance-Related Disorders | 1 | 2018 | 2038 | 0.02 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.02 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2005 | 635 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| In Vitro Techniques | 1 | 2006 | 1027 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Genome, Viral | 1 | 2004 | 13157 | 0.01 | Why? |
| Cattle | 1 | 2006 | 1336 | 0.01 | Why? |
| Endothelium, Vascular | 1 | 2012 | 1751 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Molecular Structure | 1 | 2006 | 1539 | 0.01 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2006 | 881 | 0.01 | Why? |
| Fibrinogen | 1 | 2006 | 1048 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2004 | 27595 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.01 | Why? |
| Models, Statistical | 1 | 2012 | 5312 | 0.01 | Why? |
| Computational Biology | 1 | 2009 | 4514 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Hospitalization | 1 | 2004 | 54280 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Communicable Diseases, Emerging | 1 | 2004 | 2523 | 0.01 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.01 | Why? |